MENU
+Compare
EQ
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$0.31
Change
-$0.03 (-8.82%)
Capitalization
11.07M

EQ Equillium Forecast, Technical & Fundamental Analysis

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need... Show more

Industry: #Biotechnology
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EQ with price predictions
Jun 27, 2025

EQ in upward trend: price may jump up because it broke its lower Bollinger Band on June 23, 2025

EQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where EQ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EQ's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where EQ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EQ just turned positive on June 25, 2025. Looking at past instances where EQ's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EQ advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EQ as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.047) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). EQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.361) is also within normal values, averaging (252.247).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EQ is expected to report earnings to fall 44.78% to -18 cents per share on August 06

Equillium EQ Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Missed
by $0.05
Q4'24
Beat
by $0.15
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.16
The last earnings report on May 08 showed earnings per share of -33 cents, missing the estimate of -28 cents. With 1.08K shares outstanding, the current market capitalization sits at 11.07M.
A.I. Advisor
published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELH45.890.47
+1.03%
Celsius Holdings
FLYW11.410.07
+0.62%
Flywire Corp
BOLT5.61-0.14
-2.43%
Bolt Biotherapeutics Inc
CRNC9.44-0.29
-2.98%
Cerence
NTIC7.85-0.41
-4.96%
Northern Technologies International Corp

EQ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MIST. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
N/A
MIST - EQ
45%
Loosely correlated
-1.59%
MTNB - EQ
38%
Loosely correlated
-2.32%
IMNM - EQ
31%
Poorly correlated
-0.23%
PRQR - EQ
25%
Poorly correlated
-5.56%
MURA - EQ
25%
Poorly correlated
N/A
More